Your browser doesn't support javascript.
loading
Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma.
Arroyo-Berdugo, Yoana; Alonso, Santos; Ribas, Gloría; Ibarrola-Villava, Maider; Peña-Chilet, María; Martínez-Cadenas, Conrado; Gardeazabal, Jesús; Ratón-Nieto, Juan Antonio; Sánchez-Díez, Ana; Careaga, Jesús María; Pérez-Yarza, Gorka; Carretero, Gregorio; Martín-González, Manuel; Gómez-Fernández, Cristina; Nagore, Eduardo; Asumendi, Aintzane; Boyano, María Dolores.
Afiliação
  • Arroyo-Berdugo Y; Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
  • Alonso S; Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
  • Ribas G; Department of Hematology and Medical Oncology, Instituto Investigación Sanitaria, INCLIVA, Valencia, Spain.
  • Ibarrola-Villava M; Department of Hematology and Medical Oncology, Instituto Investigación Sanitaria, INCLIVA, Valencia, Spain.
  • Peña-Chilet M; Department of Hematology and Medical Oncology, Instituto Investigación Sanitaria, INCLIVA, Valencia, Spain.
  • Martínez-Cadenas C; Department of Medicine, University of Castellon Jaume I, Castellon, Spain.
  • Gardeazabal J; Department of Dermatology, Ophthalmology and Otorhinolaryngology, UPV/EHU, Service of Dermatology, BioCruces Health Research Institute, Cruces University Hospital, Barakaldo, Bizkaia, Spain.
  • Ratón-Nieto JA; Department of Dermatology, Ophthalmology and Otorhinolaryngology, UPV/EHU, Service of Dermatology, BioCruces Health Research Institute, Cruces University Hospital, Barakaldo, Bizkaia, Spain.
  • Sánchez-Díez A; Department of Dermatology, Ophthalmology and Otorhinolaryngology, UPV/EHU, Service of Dermatology, BioCruces Health Research Institute, Basurto University Hospital, Bilbao, Bizkaia, Spain.
  • Careaga JM; Department of Dermatology, Ophthalmology and Otorhinolaryngology, UPV/EHU, Service of Dermatology, BioCruces Health Research Institute, Basurto University Hospital, Bilbao, Bizkaia, Spain.
  • Pérez-Yarza G; Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
  • Carretero G; Department of Dermatology, Doctor Negrin Hospital, Las Palmas de Gran Canaria, Spain.
  • Martín-González M; Department of Dermatology, Ramón y Cajal Hospital, Madrid, Spain.
  • Gómez-Fernández C; Deparment of Dermatology, La Paz University Hospital, Madrid, Spain.
  • Nagore E; Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.
  • Asumendi A; Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
  • Boyano MD; Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
PLoS One ; 9(4): e95522, 2014.
Article em En | MEDLINE | ID: mdl-24743186
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anexina A5 / Fosfoproteínas Fosfatases / Melanoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anexina A5 / Fosfoproteínas Fosfatases / Melanoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article